| post date: | nov 30,2021 |
| expiry date: | nov 30,2022 |
| detailed description: |
cas no. :1009119-65-6
specs:corporation standard payment method: t/t product name: daclatasvir hcl cas number: 1009119-65-6 carbamic acid, n,n'-[[1,1'-biphenyl]-4,4'-diylbis[1h-imidazole-5,2-diyl(2s)-2,1-pyrrolidinediyl[(1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester; dimethyl (2s,2's)-1,1'-((2s,2's)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1h-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate; methyl [(2s)-1-{(2s)-2-[5-(4'-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1h-imidazol-5-yl}-4-biphenylyl)-1h-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate; daclatasvir |
| cas registry number: | 1009119-65-6 |
| synonyms: | ;n,n'-[[1,1'-biphenyl]-4,4'-diylbis[1h-imidazole-5,2-diyl-(2s)-2,1-pyrrolidinediyl[(1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;daclatasvir dihydrochloride;daclatasvir.2hcl; |
| molecular structure: | 
|
